Breaking News

CordenPharma Transfers Assets to Chemie Uetikon

Will focus on peptide synthesis, specialized ingredient capabilities

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

CordenPharma Switzerland LLC, an API manufacturing facility in Liestal, has transferred its Amino Acid Building Blocks product portfolio to CU Chemie Uetikon GmbH, based in Lahr, Germany. Following the transfer, CordenPharma will focus on growing its core peptide synthesis and specialized ingredient manufacturing capabilities, including carbohydrates and synthetic lipids.   CordenPharma identified Chemie Uetikon as an ideal partner for larger scale manufacturing of amino acid building blocks, an...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters